ALBANY, N.Y, Nov. 16, 2020 /PRNewswire/ -- Immunoglobulins (Ig) refer to glycoproteins created by plasma cells. The global immunoglobulins market is foreseen to experience upward graph of revenues during assessment period of 2018 to 2026. This growth is attributed to plethora of factors. One of the key factors fueling market growth is increased use of these glycoproteins in various applications including immunology, hematology, and neurology.
Analysts at Transparency Market Research are of the opinion that the global immunoglobulins market is likely to garner the valuation of around US$ 20,757 Mn by the end of assessment period. One of the important factors fueling market demand is notable increase in number of populace living with various health issues associated with immunology, neurology, and hematology.
Request for Analysis of COVID-19 Impact on Immunoglobulins Market – https://www.transparencymarketresearch.com/covid19.php
Key Findings of Immunoglobulins Market Report
- The immunoglobulins market is predicted to show higher single digit growth during the forecast period 2018–2026.
- Thus, the market is estimated to reach valuation of approximately US$ 20,757 Mn by 2026 end.
- Of the various applications, neurology is dominant segment in the immunoglobulins market.
- In terms of route of administration, the intravenous segment accounted for lion's share in the market during 2017.
- The abovementioned segment is foreseen to maintain its leading position during assessment period.
- Another segment subcutaneous is likely to show promising growth in the market during forecast period of 2018 to 2026.
- On regional front, North America is dominant segment in the immunoglobulins market.
Explore 188 pages of top-notch research, incisive insights, and detailed country-level projections on Immunoglobulins Market (Applications - Neurology, Immunology, Hematology; Route of Administration - Intravenous, Subcutaneous, Intramuscular; End user - Hospital, Clinic, Homecare) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026 at https://www.transparencymarketresearch.com/report-toc/52353
Immunoglobulins Market: Key Driving Factors and Promising Avenues
- The market for immunoglobulins is anticipated to gain promising growth opportunities on the back of growing awareness and increased acceptance of immunoglobulins products in the healthcare sector across the globe.
- The advanced healthcare infrastructure together with increased product launch activities is likely to fuel the growth of the global immunoglobulins market from 2018 to 2026.
- Rising number of patients with autoimmune and neurological disorders will fuel market growth in the years to come. In addition to this, increase in cases of various diseases such as autoimmune hemolytic anemia, primary humoral immunodeficiency, multiple sclerosis, kawasaki syndrome, and immune thrombocytopenia purpura is estimated to help in driving the sales of immunoglobulins market in the upcoming years.
- In recent period, there is remarkable growth in older population in all worldwide locations. This population base is at high risk of acquiring various diseases including autoimmune disease. This factor is likely to boost the demand opportunities in global immunoglobulins market during the assessment period.
- However, the market for immunoglobulins is likely to experience sluggish growth owing to expensive nature of treatments and critical side effects related to infusions.
Request Brochure of Immunoglobulins Market Report - https://www.transparencymarketresearch.com/brochure.php
Immunoglobulins Market: Competitive Assessment
- Major enterprises operating in the immunoglobulins market are growing focus on employing various strategies such as mergers, acquisitions, and collaborations. These moves are helping them grow regional presence as well as gain leading position in the market for immunoglobulins.
- This aside, many vendors are investing heavily in research and development activities. Owing to all these activities, the global immunoglobulins market is predicted to show upward revenues curve during the forecast period.
- The list of important companies working in the immunoglobulins market includes CSL Behring, Shire, Grifols, S.A., Kedrion Biopharma Inc, China Biologic Products Holdings Inc, Octapharma, Sanquin, LFB SA, and Biotest AG.
Purchase the Immunoglobulins Market Report - https://www.transparencymarketresearch.com/checkout.php
The immunoglobulins market can be segmented as follows:
By Applications
- Neurology
- Immunology
- Hematology
- Others
By Route of Administration
- Intravenous
- Subcutaneous
- Intramuscular
By End-user
- Hospital
- Clinic
- Homecare
By Region
North America
- The U.S.
- Canada
Europe
- The U.K.
- Germany
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- India
- China
- Japan
- Australia & New Zealand
- Rest of Asia Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- South Africa
- GCC Countries
- Rest of Middle East & Africa
Explore Transparency Market Research's award-winning coverage of the global Healthcare Industry:
Subcutaneous Immunoglobulin Market: According to the report, the global subcutaneous immunoglobulin market was valued at US$ 4.0 Bn in 2018 and is anticipated to expand at a CAGR of 13.1% from 2019 to 2027, rise in prevalence of autoimmune disorders, Increase in global geriatric population, Growing usage in off-label indications are projected to drive the global market
Primary Immunodeficiency Market: Some of the key areas within the primary immunodeficiency market that are currently being investigated include the role of follicular T cells in the development of antibody responses, the link between impaired B-cell maturation and inflammatory conditions, inflammatory and autoimmune manifestations, and recently discovered gene defects.
Intravenous Immunoglobulin Market: The global intravenous immunoglobulin market continues to expand at a high growth rate. The market is driven by rise in global prevalence of autoimmune diseases such as primary humoral immunodeficiency (PIDD), multiple sclerosis, immune thrombocytopenia purpura (ITP), autoimmune hemolytic anemia, and Kawasaki syndrome.
Browse Our Latest Reports - https://www.transparencymarketresearch.com/latest.htm
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."
Browse More Upcoming Reports by Transparency Market Research: https://www.transparencymarketresearch.com/upcoming.htm
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Press Release Source: https://www.transparencymarketresearch.com/pressrelease/immunoglobulins-market.htm
Website: https://www.transparencymarketresearch.com/
SOURCE Transparency Market Research
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
